Qure.ai, a global leader in healthcare AI, has been awarded its 12th patent in India by the Indian Patent Office for “A system and method for detecting lung abnormalities in a medical image.”
This milestone marks Qure.ai’s first patent involving a large language model (LLM), underscoring the company’s cutting-edge advancements in medical imaging and AI. Qure.ai is a health tech company that uses deep learning and Artificial Intelligence (AI) to make healthcare more accessible and equitable for patients worldwide. With this latest addition, Qure.ai’s global patent portfolio now totals 29.
The newly patented system integrates imaging AI with LLM models to combine image analysis and patient data for highly accurate diagnoses. It provides an abnormality confidence score, enhancing diagnostic reliability, and tracks lung abnormalities over time, assisting in disease progression monitoring and treatment planning.
The model is self-evolving, continuously improving with each input and staying current with the latest medical knowledge. It is designed for scalability, incorporating new medical data and imaging techniques while seamlessly integrating with hospital information systems and electronic health records (EHRs).
Bunty Kundnani, Chief Regulatory Affairs Officer at Qure.ai, says: “We take immense pleasure in announcing Qure.ai’s 12th patent in India. This patent is a testament to our ongoing efforts to innovate and transform healthcare with AI, ultimately benefiting patients and medical professionals alike. We are excited about the future and the continued impact of our innovations on global health.”
Qure.ai’s presence is in over 90 countries and more than 2,700 sites and has positively impacted over 20 million lives to date.
The company’s patent portfolio includes a wide range of innovations, from advanced image analysis and pattern recognition to workflow optimization, decision support systems, and quality assurance in healthcare AI.
